Clinical trial
The Role of Amylin and Glucagon in T1DM
NCT00206258 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00206258 |
|---|---|
| Title | The Role of Amylin and Glucagon in T1DM |
| Official title | The Role of Amylin and Glucagon in the Management of Normalizing Glucose Excursions in Children With Type 1 Diabetes |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Pramlintide and glucagon |
| Enrollment | 30 |
| Start date | Jul 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: